Jeff Auxier's JNJ Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 71,828 shares of Johnson & Johnson (JNJ) worth $13.32 M, representing 1.87% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in JNJ, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 18,300 shares. Largest reduction occurred in Q4 2015, reducing 4,800 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Johnson & Johnson (JNJ) Holding Value Over Time
Track share changes against reported price movement
Quarterly Johnson & Johnson (JNJ) Trades by Jeff Auxier
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +97,578 | Add 0.00% | 97,577 | $85.86 |
| Q4 2013 | -125 | Reduce 0.13% | 97,452 | $91.59 |
| Q1 2014 | -215 | Reduce 0.22% | 97,237 | $98.23 |
| Q2 2014 | -3,136 | Reduce 3.23% | 94,101 | $104.62 |
| Q3 2014 | -375 | Reduce 0.40% | 93,726 | $106.59 |
| Q4 2014 | -400 | Reduce 0.43% | 93,326 | $104.57 |
| Q1 2015 | -1,650 | Reduce 1.77% | 91,676 | $100.60 |
| Q2 2015 | +250 | Add 0.27% | 91,926 | $97.46 |
| Q3 2015 | +18,300 | Add 19.91% | 110,226 | $93.35 |
| Q4 2015 | -4,800 | Reduce 4.35% | 105,426 | $102.72 |
| Q1 2016 | -250 | Reduce 0.24% | 105,176 | $108.20 |
| Q2 2016 | -50 | Reduce 0.05% | 105,126 | $121.30 |
| Q3 2016 | -950 | Reduce 0.90% | 104,176 | $118.13 |
| Q4 2016 | -100 | Reduce 0.10% | 104,076 | $115.21 |
| Q1 2017 | -650 | Reduce 0.62% | 103,426 | $124.55 |
| Q2 2017 | -25 | Reduce 0.02% | 103,401 | $132.29 |
| Q3 2017 | -550 | Reduce 0.53% | 102,851 | $130.01 |
| Q4 2017 | -2,396 | Reduce 2.33% | 100,455 | $139.72 |
| Q1 2018 | -425 | Reduce 0.42% | 100,030 | $128.15 |
| Q2 2018 | -670 | Reduce 0.67% | 99,360 | $121.34 |
| Q3 2018 | -300 | Reduce 0.30% | 99,060 | $138.17 |
| Q4 2018 | -2,180 | Reduce 2.20% | 96,880 | $129.05 |
| Q1 2019 | -75 | Reduce 0.08% | 96,805 | $139.79 |
| Q2 2019 | -2,900 | Reduce 3.00% | 93,905 | $139.28 |
| Q3 2019 | -100 | Reduce 0.11% | 93,805 | $129.37 |
| Q4 2019 | -235 | Reduce 0.25% | 93,570 | $145.87 |
| Q1 2020 | -470 | Reduce 0.50% | 93,100 | $131.13 |
| Q2 2020 | -2,640 | Reduce 2.84% | 90,460 | $140.63 |
| Q3 2020 | -245 | Reduce 0.27% | 90,215 | $148.88 |
| Q4 2020 | -267 | Reduce 0.30% | 89,948 | $157.38 |
| Q1 2021 | -190 | Reduce 0.21% | 89,758 | $164.35 |
| Q2 2021 | -3,975 | Reduce 4.43% | 85,783 | $164.74 |
| Q3 2021 | -188 | Reduce 0.22% | 85,595 | $161.50 |
| Q4 2021 | -2,205 | Reduce 2.58% | 83,390 | $171.08 |
| Q1 2022 | -2,969 | Reduce 3.56% | 80,421 | $177.23 |
| Q2 2022 | -1,500 | Reduce 1.87% | 78,921 | $177.51 |
| Q3 2022 | -2,071 | Reduce 2.62% | 76,850 | $163.36 |
| Q4 2022 | -60 | Reduce 0.08% | 76,790 | $176.65 |
| Q1 2023 | +1,985 | Add 2.58% | 78,775 | $155.00 |
| Q2 2023 | +491 | Add 0.62% | 79,266 | $165.52 |
| Q3 2023 | -3,001 | Reduce 3.79% | 76,265 | $155.75 |
| Q4 2023 | -733 | Reduce 0.96% | 75,532 | $156.74 |
| Q1 2024 | -902 | Reduce 1.19% | 74,630 | $158.19 |
| Q2 2024 | -1,851 | Reduce 2.48% | 72,779 | $146.16 |
| Q3 2024 | -158 | Reduce 0.22% | 72,621 | $162.06 |
| Q4 2024 | -160 | Reduce 0.22% | 72,461 | $144.62 |
| Q1 2025 | -92 | Reduce 0.13% | 72,369 | $165.84 |
| Q2 2025 | -233 | Reduce 0.32% | 72,136 | $152.75 |
| Q3 2025 | -308 | Reduce 0.43% | 71,828 | $185.42 |
Jeff Auxier's Johnson & Johnson Investment FAQs
Jeff Auxier first purchased Johnson & Johnson (JNJ) in Q2 2013, acquiring 97,577 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Johnson & Johnson (JNJ) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier's largest addition to Johnson & Johnson (JNJ) was in Q2 2013, adding 97,577 shares worth $8.38 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 71,828 shares of Johnson & Johnson (JNJ), valued at approximately $13.32 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Johnson & Johnson (JNJ) represents approximately 1.87% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier's peak holding in Johnson & Johnson (JNJ) was 110,226 shares, as reported at the end of Q3 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.